Abstract In order to determine whether oxytocin release is controlled by an osmoreceptor mechanism identical with that for vasopressin release, the plasma oxytocin concentration and plasma osmolality were measured during intraatrial infusion and after intraventricular injection of various osmotic solutions in unanesthetized rats. Intraatrial infusion of 0.6 M NaCI Locke solution (LS.) or 1.2 M mannitol L.S. elevated plasma oxytocin significantly, while 1.2 M urea L.S. caused only a small increase and isotonic L.S. did not change in plasma oxytocin. All hypertonic solutions produced significant and similar increases in the plasma osmolality. Plasma oxytocin was positively correlated with plasma osmolality in the animals infused with hypertonic NaCI or mannitol but not in the animals infused with hypertonic urea. The injection of 2 tl of 0.6 M NaCI artificial cerebrospinal fluid (CSF) or 1.2 M mannitol CSF into the third ventricle caused a significant increase in plasma oxytocin immediately (5 min after injection) without changing plasma osmolality, while the intraventricular injection of 1.2 M urea CSF or isotonic CSF produced no significant change in plasma oxytocin. These results indicate that oxytocin release is controlled by osmoreceptors rather than Na receptors, that the adequate stimulus for the osmoreceptors is one which produces cellular dehydration and that the osmoreceptors are located in the brain region which is accessible to osmotic agents from both the outside and inside of the bloodbrain barrier. Since the organum vasculosum of the lamina terminalis (OVLT) lacks a blood-brain barrier and is known to be involved in osmotic control of vasopressin release, a lesion was made in the anteroventral region of the third ventricle which encompasses the OVLT and the effect of hypertonic NaCI infusion on oxytocin release was examined. No significant increase in plasma oxytocin was observed after intraatrial infusion of 0.6 M NaCI L.S. in the lesioned rats. All of these findings lead to the conclusion that oxytocin release is under the control of osomoreceptors identical to those for vasopressin release.
Since VERNEY (1947) proposed the hypothalamic osmoreceptor theory, many investigations have been conducted to elucidate the specific mechanisms for osmotic control of vasopressin secretion. And it is now widely accepted that there are cranial osmoreceptors for vasopressin release, which are excited when the receptor cells are dehydrated due to withdrawal of water from the cells by osmotic agents which hardly permeate the cell membrane, such as NaCI, sucrose and mannitol (SLADEK and KNIGGE, 1977; THRASHER et al., 1980a, b) although the precise location of the osmoreceptors is somewhat controversial (LENG et al., 1982; THRASHER et al., 1982; SLADEK and JOHNSON, 1983; HONDA et al., 1987) . Recently it has been shown that oxytocin, the other neurohypophysial hormone, is also secreted in response to hypertonlc NaCI In rats (JONES and PICKERING,1969; BRIMBLE et al., 1978; BALMENT et al., 1980) . However, it is not yet known whether oxytocin is released by the same osmoreceptor mechanism as that for vasopressin release. Oxytocin has been shown to be released by general stress (LANG et al., 1983; GIBBS, 1984; HIGUCHI et al., 1986) . Thus the possibility remains that hypertonlc NaCI may act as nonspecific stressful stimuli. As a physiological role of oxytocin secreted in response to hypertonlc NaCI, oxytocin is found to have a natriuretic action (BALMENT et al., 1986) rather than an antidiuretic effect in normal rats. This finding suggests that oxytocin release is possibly controlled by a Na receptor mechanism rather than osmoreceptors.
In an attempt to clarify the situation, the present studies were carried out to assess the validity of the working hypothesis that oxytocin release is controlled by the same osmoreceptor mechanism as vasopressin release.
MATERIALS AND METHODS
Animals. All experiments were carried out in male Wistar rats weighing 300-380 g. The rats were housed in a light-controlled (10 h dark and 14 h light) and airconditioned room (23±2 C). They were allowed free access to pelleted food (CE7, Clea) and tap water.
Preparation of solutions. Hypertonic (1.2 Osm/l) solutions for intraatrial infusion were prepared by adding either NaCI, mannitol or urea to isotonic Locke solution (L.S.). The composition of isotonic L.S. was as follows (mM): Na 158, K 5.6, Ca 3.0, Cl 165.6, and HC03 1.8. Hypertonic (1.2 Osm/l) solutions for intraventricular injection were prepared using artificial cerebrospinal fluid (CSF) to which an appropriate amount of NaCI, mannitol or urea was added. The compositions of artificial CSF was as follows (mM): Na 148.3, K 3.0, Ca 1.2, Mg 0.9, C1 135.2, HCO3 20, and H2P04 0.3.
Procedures for intraatrial infusion experiment. In 32 rats a cannula (Silastic, Dow Corning) was chronically implanted into the right atrium through the jugular vein under ether anesthesia 1 day before the experiment. The rats were divided into 4 groups. Plasma osmolality in 3 individual groups of rats was raised by infusion of either 0.6 M NaCI, 1.2 M mannitol, or 1.2 M urea through the cannula.
Rats in the remaining group were infused with isotonic Locke solution as the control. Each solution was infused at the rate of 1 pl/s for 60 min with a peristaltic pump (Microperpex Peristaltic Pump, LKB). Blood samples (0.6 ml each) were taken before infusion, after 30 min infusion, and after 60 min infusion. Blood was withdrawn slowly (20-30 s per sampling) and immediately replaced by an equal volume of isotonic saline. Since infusion of a solution and blood sampling were done through the same cannula, 0.2 ml of blood was taken and was discarded in order to clear the cannula before the second and third blood sampling. And the infusion of a solution was interrupted for a period of about 3 min at the second blood sampling. A 0.6 ml sample was centrifuged and the plasma removed. A 20 pl aliquot of the plasma was used for osmolality determination and the remainder stored at -20 GC until radioimmunoassayed for oxytocin.
Procedures f or intraventricular injection experiment. A cannula was implanted chronically in the third ventricle of 34 rats obliquely from the front towards the back 7 days before the experiment under pentobarbital anesthesia (40 mg/kg, i.p.). The cannula was made of a stainless steel guide tube (0.6 mm o.d.) and a stainless steel inner cannula (0.3 mm o.d.). The correct placement of the cannula was checked by observing the outflow of CSF from the outer end of the guide tube, and then it was fixed on the skull with small screws and dental cement. An atrial cannula was placed through the right jugular vein for blood sampling 1 day before the experiment. The animals were divided into four groups, each of which was injected with 2 pl of the hypertonic or isotonic artificial CSF solution into the third ventricle. Two control blood samples (0.2 ml each) were taken at a 15 min interval before the intraventricular injection and three test blood samples were taken 5, 15, and 60 min after the injection to determine plasma oxytocin and plasma osmolality. All samples were centrifuged and fresh plasma samples used for osmolality determination. The remaining plasma was stored at -20 GC for oxytocin assay.
Procedures for lesion experiment. Six days before the experiment a lesion in the anteroventral region of the third ventricle (AV3V) and sham lesion were made under pentobarbital anesthesia in 15 and 7 male rats, respectively. The rat was fixed in a stereotaxic frame and a hole was drilled on the midsagittal suture. A lesion electrode of stainless steel tubing with a platinum tip (0.2 mm diameter), which was insulated with epoxylite except for 0.5 mm at the tip, was lowered to the calculated depth through the hole. The coordinates were obtained from the atlas of ALBE-FESSARD et al. (1966) . An anodal lesion was produced with 1 mA DC current for 20 min. For sham lesion the electrode was lowered similarly but no current was passed through. Intraatrial cannulation was performed 1 day before the experiment. On the day of the experiment the infusion of 0.45 M NaCI and blood samplings 0, 30, and 60 min after the onset of the infusion were carried out. Other procedures were the same as described for the "procedures for intraatrial infusion experiment."
Osmolality determination. Plasma asmolalities were measured by the vapor pressure method (Shimadzu Osmometer, OSM-1). The intra-run coefficient of variance was 1.7% and the inter-rup coefficient of variance 2.6%. Correlation H. NEGORO, T. HIGUCHI, Y. TADOKORO, and K. HONDA between values measured by this method and those by freezing point depression method (Knauer Semi-micro Osmometer) using plasma obtained from variously hydrated or dehydrated rats (n =13) was highly significant (r = 0.95, p <0.001), although the vapor pressure method gave slightly but significantly lower values than the freezing point depression method (the mean difference + S.E., 15.5 + 1.9, p <0.01, paired t-test). The regression equation was Y= 0.84 (X+ 43.0), where Y is a value of the vapor pressure method and X a value of the freezing point depression method. Osmolalities of NaCI solutions (n =11) of various concentrations (0.27-0.40 M) were also measured by the two methods but no significant difference was found between values by the vapor pressure method and those by freezing point depression method. Oxytocin assay. Oxytocin concentrations were determined by radioimmunoassay as reported previously (HIGUCHI et al., 1985) . All samples were assayed in a single run. The minimum detectable level of the assay was 3.3 pg/ml. The intrassay coefficient of variance was 5.3%.
Histological analysis. After the experiments, the animals were deeply anesthetized with urethane and perfused intracardially with 0.9% saline followed by 10% formalin. Frozen brains were cut at 50 pm and stained with neutral red. Cannula placement or lesion sites were inspected and data from animals with verified placements were included for analysis.
Statistics. Group data are expressed as mean + SE. Paired t-tests were used to evaluate the change in preinfusion or preinjection versus postinfusion or postinjection values for each rat. Independent t-tests were used when different groups of rats were compared. The level of statistical significance was set at the p < 0.05 level.
RESULTS

Effect o f intraatrial infusion o f various hypertonic solutions and isotonic Locke solution on plasma oxytocin concentration
The infusion of 0.6 M NaCI Locke solution (L.S.), 1.2 M mannitol L.S., 1.2 M urea L.S., or isotonic L.S. was made via an atrial Cannula at 1 ill/s for 60 min in conscious rats. The change in the plasma osmolality and plasma oxytocin concentration before, 30 min after, 60 min after the start of the infusion is shown in Fig.  1 . Infusion of 0.6 M NaCI L.S. resulted in a significant increase in plasma osmolality (p <0.05 both 30 and 60 min after infusion) and at the same time the plasma oxytocin level became 3.3-fold as high as the preinfusion level after 30 min infusion (p < 0.0 I) and 5.7-fold after 60 min infusion (p<0.01). Infusion of 1.2M mannitol L.S. brought about similar results: a significant elevation in plasma osmolality (p <0.01 after 30 and 60 min infusion) and a 2.3-fold increase (p <0.01) after 30 min infusion and 6-fold increase (p <0.001) after 60 min infusion in plasma oxytocin. On the other hand, the infusion of 1.2 M urea L.S. produced only a small increase in plasma oxytocin (by 1.4-fold after 30 min and by 1.5-fold after 60 min infusion), in OSMORECEPTORS   AND  OXYTOCIN  RELEASE  23 spite of a significant increase in plasma osmolality (p <O.OI after 30 and 60min infusion) similar to those produced by the other hypertonic solutions. Though it was small, the plasma oxytocin concentration after 60 min infusion of 1.2 M urea was significantly higher (p <O.05) than the control value. Infusion of isotonic L.S. showed no significant change either in plasma osmolality or in plasma oxytocin.
The relationship of plasma oxytocin to plasma osmolality was investigated in each group of experiments (Fig. 2) . In 0.6 M NaCI L.S.-infused animals, a linear regression line (plasma oxytocin = 5.0 x (plasma osmolality -271.0)) has been fitted to the data by the least squares method, and there was a significant positive correlation (r=0.60, p <0.005) between plasma oxytocin and plasma osmolality. Similarly in 1.2 M mannitol L.S.-infused animals, the plasma oxytocin concentration was positively correlated (r = 0.52, p <0.01) with plasma osmolality and the formula for the linear regression line was plasma oxytocin = 4.1 x (plasma osmolality-267.4).
On the other hand, in L2 M.urea L.S.-infused animals, no significant correlation (t=0.14) was found between the plasma oxytocin concentration and plasma osmolality. Effect o f intraventricular injection o f various hypertonic solutions on plasma oxytocin concentration Changes in the plasma oxytocin concentration before and after the injection of 2R1 of 0.6 M NaCI CSF, 1.2 M mannitol CSF, 1.2 M urea CSF, or artificial CSF into the third ventricle in conscious rats are shown in Fig. 3 . A significant (p < O.O l ) increase in plasma oxytocin occurred 5 min after the injection of hypertonic NaCI CSF or hypertonic mannitol CSF, whereas no significant change was found in plasma oxytocin levels following the injection of 1.2 M urea CSF or isotonic artificial CSF. Plasma osmolality showed no significant change in response to intraventricular injection of each of the solutions. The effect o f lesions o f the anteroventral region o f the third ventricle (A V3 V) on osmotically-induced oxytocin secretion Plasma osmolality and oxytocin release in response to 0.6 M NaCI L.S. infusion for 0, 30, and 60 min AV3V lesioned rats (n = 10) were compared with those in sham-lesioned rats (n=7). The results are shown in Fig. 4 . The mean plasma osmolality in lesioned rats was always significantly (p <0.02) higher than that in sham-lesioned rats throughout the experiment. However, in both types of rats it increased significantly as the infusion progressed. On the other hand, the control value for the plasma oxytocin concentration in lesioned rats did not differ significantly from that in sham-lesioned rat in spite of the significant difference between the corresponding values for plasma osmolality. And in lesioned rats no significant change was observed in the plasma oxytocin concentration throughout the infusion period, while in sham-lesioned rats plasma oxytocin increased to 2.8-fold after 30 min infusion (p <0.01, paired t-test) and to 4.9-fold after 60 min infusion (p <0.001, paired t-test). A comparison of oxytocin levels in lesioned and sham-lesioned groups also showed a significant difference after 30 (p <0.001, t-test) and 60 min infusion (p <0.001, t-test). The structures damaged by lesions were histologically examined and it was found that in 5 out of 151esioned rats the lesion missed the AV3V. Data obtained from these rats were not included in the above mentioned analysis. The damaged structures in the remaining 10 rats were reconstructed as shown in Fig. 5 . The lesion extended dorsally to the level below the anterior commissure, ventrally into the optic chiasm, rostrally to the diagonal band of Broca, and caudally to the suprachiasmatic nuclei. The organum vasculosum of the lamina terminalis (OVLT) was included in the lesioned structures of the 10 rats.
DISCUSSION
In this study we employed the vapor pressure method for determination of plasma osmolalities in order to minimize the volume of blood samples withdrawn repeatedly. The values of rat plasma osmolalities were somewhat lower than those determined by the freezing point depression method in other studies; the mean plasma osmolality of euhydrated rats was 280.6 + 0.99 in this study, whereas it was described to be 293.6± 1.4 mOsm/kg by DUNN et al., (1973) and 299 ± 2 mOsm/kg by BALMENT et al. (1980) . The discrepancy seems mainly due to the difference in methods for measuring plasma osmolalities. In our pilot study (see MATERIALS AND METHODS) the values of rat plasma osmolalities measured by the two methods indicated a strong correlation but the values measured by the vapor pressure method were significantly lower than those by the freezing point depression method, while the values of osmolalities of saline of various concentration measured by the two methods did not show a significant difference. Therefore some factor(s) in rat plasma may produce the difference in measured values of osmolality between the two methods. It has been shown that volatile solutes in the serum such as ethanol and ketones influence the values of osmolalities measured by the vapor pressure method (Rocco, 1976) . However, further investigations are required to (PELLEGRINO et al., 1979) showing the superimposed outlines of AV3V lesions produced in 10 rats. Abbreviations: CA, anterior commissure; CO, optic chiasm; DBB, diagonal band of Broca; LS, lateral septum; MS, medial septum; POA, preoptic area; SO, supraoptic nucleus.
H. NEGORO, T. HIGUCHI, Y. TADOKORO, and K. HONDA clarify the reason why the osmolality of rat plasma is measured differently by the vapor pressure and freezing point depression methods. In the present study not only peripheral infusion but also intraventricular injection of hypertonic NaCI or mannitol stimulated the release of oxytocin. This indicates that osmoreceptors for oxytocin release are located in the brain region, although the possibility remains that the peripheral osmoreceptors (ADACHI et al., 1976; ARSENIJEVIC, 1985) are also involved in the control of oxytocin secretion. Furthermore, intraatrial or intraventricular administration of solutes such as NaCI or mannitol to which cell membranes are relatively impermeable caused a marked increase in plasma oxytocin, while that of urea which penetrates cell membranes produced only a small increase or no change in plasma oxytocin. On the whole, the findings fit Verney's concept of osmoreception (VERNEY, 1947) that is postulated as a control mechanism for vasopressin secretion, i.e. the effectiveness of an osmotic agent is related to the permeability of cell membrane for that agent. Although small, there was a significant increase in plasma oxytocin following intraatrial infusion of 1.2 M urea L.S. for 60 min. But this does not seem to be a phenomenon unique to oxytocin release. MCKINLEY et al. (1978) who investigated the effect of the infusion of various hypertonic solutions on free water clearance in conscious sheep also observed that 4.6 or 2 M urea caused a reduction in free water clearance, although the change occurred more slowly than when hyperosmotic NaCI or sucrose was infused. They attributed this phenomenon to the presence of sensor elements situated in brain regions which possess a blood-brain barrier to urea. This explanation is also applicable to the oxytocin release following hypertonic urea infusion which was observed in the present study.
Verney's concept of the osmoreceptor has been confronted with the problem of whether the receptors involved in mediating vasopressin releases and thirst are sensitive to changes in osmolality per se or to sodium concentration, because when plasma osmolality is increased, waterr is withdrawn from brain tissue across the blood-brain barrier, and an increase in both sodium concentration and osmolality of CSF is caused. ANDERSSON (1971) suggested that Na receptor cells are involved in control of vasopressin and thirst, mainly on the basis of experiments showing that the administration of hypertonic sucrose into CSF does not stimulate thirst and antidiuresis while that of hypertonic NaCI does. However, the findings in more recent studies seem to contradict the Na receptor concept; the organ-cultured explant of the rat hypothalamo-neurohypophyseal system releases vasopressin in response to an increase in osmolality of the culture medium due to the addition of mannitol as well as NaCI (SLADEK and KNIGGE, 1977) . Intraventricular infusion of artificial CSF made hypertonic by the addition of either NaCI or sucrose cause vasopressin release in dogs (THRASHER et al., 1980a) , and antidiuresis in sheep (MCKINLEY et al., 1978) , although hypertonic NaCI CSF produced a greater antidiuretic effect than hypertonic sucrose.CSF (MCKINLEY et al., 1978) . There has been no direct evidence that osmoreceptors rather than Na receptors play a role in the control of oxytocin release except an electrophysiological finding that identified AND OXYTOCIN RELEASE 29 oxytocin cells were excited by i.p. injection of hypertonic LiCI or mannitor (BRIMBLE et a!., 1978) . The present experiments showed that intraventricular injection of hypertonic NaC1 CSF or hypertonic mannitol CSF caused an increase in the plasma oxytocin concentration (but that of hypertonic urea did not increase). Thus it is very likely that the osmoreceptor mechanism rather than the Na receptor mechanism plays a major role also in oxytocin release, in spite of the fact that oxytocin exerts a natriuetic effect rather than an antidiuretic effect in the kidney (BALMENT et al., 1980 (BALMENT et al., , 1986 . The effect of the peripheral and central administration of hypertonic solutions on plasma oxytocin indicate that oxytocin release is controlled by the osmoreceptor cells located in the brain regions where osmotic agents can approach from both outside and inside the blood-brain barrier. The circumventricular organs (CVOs) are known to have such a characteristic feature (WEINDLE and JOYNT, 1972) . Many studies have shown that ablation of the AV3V which includes the OVLT (one of the CVOs) results in the reduction or abolishment of osmoreception for vasopressin release or antidiuresis in dogs (THRASHER et a!., 1982) and in rats (JOHNSON et a!., 1978; SLADEK and JOHNSON, 1983; GRUBER et a!., 1986) . Furthermore, we have observed that microinjection of hypertonic NaCI solution into the AV3V excited not only putative vasopressin neurones but also putative oxytocin neurones (HONDA et a!., 1987) . We therefore attempted to determine the effect of the AV3V lesion on the plasma oxytocin concentration and found that the lesion abolished the response of oxytocin release to the osmotic stimuli. RUSSEL et a!. (1984) observed that water deprivation did not alter the content of oxytocin as well as vasopressin in the neurohypophysis or magnocellular nuclei in AV3V lesioned rats indicating that the inability of oxytocin release in response to osmotic stimuli in AV3V lesioned rats is not due to depletion of the hormone from the hypothalamo-neurohypophysial system. It is also unlikely that loss of sensitivity of the oxytocin neurone to osmotic stimuli is caused by long exposure to hyperosmolality produced by AV3V lesions, because in our preliminary observation rats deprived of water for 4 days showed a good response of oxytocin release to 1.5 M NaCI injected i.p. (Higuchi et a!., unpublished data) . Thus these findings indicate that the AV3V is involved in the osmotic control of oxytocin release. The high plasma osmolality in the lesioned animals was probably caused by disruption of the osmotic control of vasopressin release (THRASHER et a!., 1982; SLADEK and JOHNSON, 1983) and/or thirst deficit (BUGGY and JOHNSON, 1977) in lesioned rats.
In conclusion the results in the present study strongly suggest that oxytocin release in rats is under the control of an osmoreceptor mechanism identical to that for vasopressin release. Recently it has been reported, however, that the plasma oxytocin concentration does not respond to osmotic stimuli in man (WILLIAMS et a!., 1986) . Thus, whether there is a species difference in osmotic control of oxytocin release remains to be clarified.
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